RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 210, Issue 11, Pages 2447-2463
Publisher
Rockefeller University Press
Online
2013-10-01
DOI
10.1084/jem.20120201
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stable RAGE-Heparan Sulfate Complexes Are Essential for Signal Transduction
- (2013) Ding Xu et al. ACS Chemical Biology
- Opposing Roles of Membrane and Soluble Forms of the Receptor for Advanced Glycation End Products in Primary Respiratory Syncytial Virus Infection
- (2012) Allison L. Miller et al. JOURNAL OF INFECTIOUS DISEASES
- Solution Structure of the Soluble Receptor for Advanced Glycation End Products (sRAGE)
- (2011) Zsuzsa Sárkány et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase
- (2011) Sarah E. Ewald et al. JOURNAL OF EXPERIMENTAL MEDICINE
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal Transduction
- (2010) Hongliang Zong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The 1.5 Å Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand Binding
- (2010) HaJeung Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Receptor for Advanced Glycation End Products (RAGE) and the Lung
- (2010) Stephen T. Buckley et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Carboxylated N-glycans on RAGE promote S100A12 binding and signaling
- (2010) Geetha Srikrishna et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons
- (2010) Josh Gregorio et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Complement C3a, CpG Oligos, and DNA/C3a Complex Stimulate IFN- Production in a Receptor for Advanced Glycation End Product-Dependent Manner
- (2010) B. H. Ruan et al. JOURNAL OF IMMUNOLOGY
- The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis
- (2010) Sami Banerjee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Chronic Inflammation in Obesity and the Metabolic Syndrome
- (2010) Rosário Monteiro et al. MEDIATORS OF INFLAMMATION
- Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells
- (2010) A. L. Blasius et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation
- (2010) K. Kawane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3
- (2010) M. Sasai et al. SCIENCE
- Structural Basis for Ligand Recognition and Activation of RAGE
- (2010) Michael Koch et al. STRUCTURE
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
- (2009) Shi Fang Yan et al. ANNALS OF MEDICINE
- Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene
- (2009) Anastasia Z. Kalea et al. FASEB JOURNAL
- Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity
- (2009) Y. J. Crow et al. HUMAN MOLECULAR GENETICS
- Recognition of 5′ Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand Virus
- (2009) Martin Schlee et al. IMMUNITY
- RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts
- (2009) Ravichandran Ramasamy et al. JOURNAL OF LEUKOCYTE BIOLOGY
- HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses
- (2009) Hideyuki Yanai et al. NATURE
- Cytoplasmic nucleic acid sensors in antiviral immunity
- (2009) Priya Ranjan et al. TRENDS IN MOLECULAR MEDICINE
- The DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation
- (2008) Tobias Haas et al. IMMUNITY
- Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
- (2008) Barry I. Hudson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural basis for translation termination on the 70S ribosome
- (2008) Martin Laurberg et al. NATURE
- The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
- (2008) Sarah E. Ewald et al. NATURE
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9
- (2008) Boyoun Park et al. NATURE IMMUNOLOGY
- V domain of RAGE interacts with AGEs on prostate carcinoma cells
- (2008) Edith Uetz-von Allmen et al. PROSTATE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started